$TECH|4Aug 22, 5:13 PM ET

BIO-TECHNE Corp 4

4 · BIO-TECHNE Corp · Filed Aug 22, 2016

Form 4

Period: 2016-08-18

SVP Clinical Controls

Transactions

Award
Stock Options (Right to Buy)
2016-08-18+13,028→ 13,028 total
Exercise: $106.59Exp: 2023-08-18→ Common Stock (13,028 underlying)
Award
Stock Options (Right to Buy)
2016-08-18+17,371→ 17,371 total
Exercise: $106.59Exp: 2023-08-18→ Common Stock (17,371 underlying)
Award
Restricted Stock Units
2016-08-18+2,111→ 2,111 total
→ Common Stock (2,111 underlying)

Holdings

Stock Options (Right to Buy)
Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying)
10,000
Common Stock
2,191
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying)
50,000
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying)
15,000

Footnotes (6)

[F1]Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
[F2]50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
[F3]Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.
[F4]Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
[F5]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F6]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Documents

2 files